SCHEMBL25663166

SCHEMBL25663166

c1ccc2sc(-c3ccc(N(c4ccc(-c5nc6ccccc6s5)cc4)c4ccc(-c5ncnc6c5sc5ccccc56)cc4)cc3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 5/20 0.50
▸ RAB9A P51151 5/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MMP9 P14780 2/20 0.44
▸ MMP8 P22894 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ LIMK1 P53667 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ AURKA O14965 2/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PAX8 Q06710 2/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663133 0.89 APP (0.46) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663123 0.82 APP (0.50) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663164 0.81 NPC1 (0.41) RAB9ANPC1KDM4EGAAMAPT
SCHEMBL25663160 0.79 LIMK1 (0.42) LIMK1CDK5CDK5R1EGFR
SCHEMBL24155385 0.79 APP (0.76) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663161 0.78 LIMK1 (0.41) LIMK1CDK5CDK5R1EGFR
SCHEMBL25663162 0.78 TDO2 (0.40) LIMK1CDK5CDK5R1EGFR
SCHEMBL25663167 0.78 ESR1 (0.40) RAB9ANPC1KDM4EMAPTALDH1A1
SCHEMBL25663153 0.78 NPC1 (0.38) RAB9ANPC1KDM4EMAPTALDH1A1
SCHEMBL14195549 0.78 APP (0.73) APPRAB9ANPC1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 APP 2850/4885RAB9A 2198/4885NPC1 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback